Prof Cora Sternberg, scientific co-chair of the 2013 European Cancer Conference, discusses the results of a study that found the prostate-specific antigen test to be harmful.

Prof Boniol, Research Director at the International Prevention Research Institute (iPRI) and Professor at the Strathclyde Institute for Global Public Health at iPRI, Lyon, France, told the congress that the total harm men experience in terms of impotence and incontinence, and the side-effects from prostate cancer treatments, severely affects their quality of life, and should further discourage the use of PSA testing for prostate cancer screening.